Publication | Closed Access

Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies

Refractory Solid MalignanciesMedicineCancer BiologyBiomarker StudyNovel Signal TransducerCancer TreatmentRadiation OncologyOncologyCell BiologyCancer ResearchCancer Growth